Cyprus PGD

practice

Cyprus PGD

A Genetics-Based IVF Approach to Reduce Inherited Disease Risk

Advances in IVF have made it possible not only to achieve pregnancy, but also to select embryos with a healthier genetic profile before transfer. This is where PGD (Preimplantation Genetic Diagnosis)—often discussed today under the broader umbrella of PGT (Preimplantation Genetic Testing)—plays an important role.

For couples who carry hereditary conditions, experience recurrent miscarriage, or face age-related chromosome risks, Cyprus PGD has become a widely searched and discussed option within the broader topic of Cyprus IVF and North Cyprus IVF treatment.

In this guide, you’ll learn what PGD is, how it works in an IVF cycle, who may benefit most, and what to consider when exploring genetic testing with IVF in Cyprus.

What Is PGD (Preimplantation Genetic Diagnosis)?

PGD is a genetic testing method performed on embryos created through IVF / ICSI before the embryo is transferred to the uterus. A small number of cells are carefully removed from the embryo (embryo biopsy), and those cells are analyzed to check for specific genetic conditions.

The main goal is to help identify embryos that are not affected by a targeted inherited disorder, so that the embryo selected for transfer is genetically more suitable based on the couple’s known risk.

Today, many clinics and patients also use the term PGT. In practice:

  • PGD is often used when testing for a known genetic disease in the family (single-gene disorders).

  • PGT is the broader term and may include chromosome screening (PGT-A), single-gene testing (PGT-M), and structural chromosome issues (PGT-SR).

Why Is PGD/PGT Used in IVF?

Genetic testing during IVF may be recommended to support:

  • Lower risk of passing on a known inherited condition

  • Better embryo selection when repeated IVF failures or miscarriages suggest genetic factors

  • More informed decision-making in age-related chromosome risk scenarios

  • Targeted prevention for families with serious genetic history

It’s important to understand that PGD/PGT is not a guarantee of a healthy baby, and it does not test for every possible disease. It is a powerful risk-reduction tool for specific indications.

PGD vs PGT: What’s the Difference?

In many “Cyprus IVF” searches, you’ll see PGD and PGT used interchangeably. Here’s the simplest way to separate them:

PGT-A (Aneuploidy Screening)

Checks for chromosome number issues (extra or missing chromosomes).
Often considered in:

  • Advanced maternal age

  • Recurrent miscarriage

  • Repeated IVF failure

PGT-M (Single-Gene Disorders)

Targets a specific known genetic condition (e.g., a disease mutation in the family).
Often considered when:

  • One or both partners are carriers

  • There is a previously affected child or strong family history

PGT-SR (Structural Rearrangements)

Checks embryos when a parent carries balanced translocation or other structural chromosome rearrangements that may lead to miscarriage or affected pregnancies.

When people say “Cyprus PGD”, they are often referring to PGT-M specifically (testing for a known inherited disease), though some also use it to describe PGT-A/PGT-SR.

Who May Benefit from Cyprus PGD / PGT?

PGD/PGT is not routine for every IVF patient. It may be considered for:

  • Couples known to be carriers of a hereditary disease

  • Families with a history of genetic disorders

  • Couples with recurrent pregnancy loss

  • Patients with repeated IVF implantation failure

  • Individuals with advanced maternal age where chromosome risks increase

  • Couples where one partner has balanced translocation or similar findings

  • Families concerned about sex-linked genetic diseases (X-linked conditions)

A thorough fertility and genetics evaluation is essential to decide whether PGD/PGT adds meaningful value in your specific case.

How Does the Cyprus PGD / PGT Process Work?

Although protocols vary across Cyprus IVF centers, the medical flow generally includes the following steps:

1) Consultation & Genetic Planning

  • Review medical history, fertility history, and miscarriage/IVF outcomes

  • Assess family genetic risks

  • Decide which test type is appropriate (PGT-A, PGT-M, PGT-SR)

If PGT-M is needed, test development may require additional preparation (depending on the condition and available family genetic information).

2) IVF / ICSI Cycle (Creating Embryos)

  • Ovarian stimulation to develop multiple follicles

  • Egg retrieval (OPU)

  • Fertilization via IVF or ICSI

  • Embryo development typically monitored to blastocyst stage (day 5)

3) Embryo Biopsy

  • A few cells are removed from the embryo’s outer layer (trophectoderm)

  • The embryo is usually frozen while genetic testing is completed

This step requires high lab precision and strict protocols to minimize stress on the embryo.

4) Genetic Testing (PGD/PGT)

  • The biopsied cells are analyzed in a genetics lab

  • Results classify embryos based on the test type:

    • Chromosome screening outcomes (PGT-A)

    • Target mutation status (PGT-M)

    • Structural balance status (PGT-SR)

Many labs use advanced platforms, including NGS (Next-Generation Sequencing), depending on the case and test.

5) Frozen Embryo Transfer (FET)

  • The uterus is prepared in a later cycle

  • A genetically suitable embryo is thawed and transferred

  • Pregnancy testing and follow-up proceed as standard IVF care

Potential Benefits of PGD/PGT in IVF

Depending on the patient profile, PGD/PGT may help with:

  • Reducing the risk of transferring an embryo affected by a known condition

  • More strategic embryo selection

  • Potentially reducing miscarriage risk in some genetic-risk scenarios

  • Supporting decision-making when multiple embryos are available

The impact differs from one couple to another and depends strongly on age, egg/sperm quality, embryo number, and the underlying fertility diagnosis.

Important Limitations and Considerations

Before choosing Cyprus PGD/PGT, it’s helpful to understand the key realities:

  • Not all embryos may be suitable after results; sometimes none are recommended for transfer

  • Embryo biopsy is highly specialized and must be performed by experienced labs

  • Testing does not cover everything; it targets specific risks and/or chromosome patterns

  • No IVF method can promise a guaranteed outcome

  • Ethical and personal factors may matter greatly, especially in cases involving sex-linked risk or family balancing discussions

A careful, individualized risk–benefit discussion is essential.

Cyprus PGD and Common IVF Search Topics

People researching Cyprus IVF, North Cyprus IVF, and Cyprus fertility clinic options often look for:

  • “PGD in Cyprus / PGT in Cyprus”

  • “Genetic testing IVF Cyprus”

  • “PGT-A vs PGD vs NGS”

  • “IVF with genetic screening Cyprus”

  • “Recurrent miscarriage genetic testing IVF”

  • “IVF ICSI PGT Cyprus”

  • “Embryo biopsy and PGT results”

  • “Frozen embryo transfer after PGT”

This is why PGD/PGT is frequently included in long-form Cyprus IVF planning discussions—especially for couples seeking a more genetics-informed pathway.

Conclusion: Cyprus PGD as a Genetics-Focused IVF Option

Cyprus PGD (Preimplantation Genetic Diagnosis)—and broader PGT testing—can be a meaningful option for couples with known hereditary risks, recurrent pregnancy loss, repeated IVF failure, or age-related chromosome concerns. It does not replace IVF; rather, it adds a genetic evaluation layer to help select embryos more strategically.

The best next step is always a personalized medical and genetic assessment, because the value of PGD/PGT depends on your fertility diagnosis, history, and goals.

  • Paylaş:

DİĞER HİZMETLER